Synonyms: MPC-7869
Compound class:
Synthetic organic
Comment: Tarenflurbil or R-flurbiprofen, is the single enantiomer of the racemate NSAID flurbiprofen. Research and trials for Alzheimer's disease were conducted by Myriad Genetics but the company discontinued development in 2008. This compound is the archetypal γ-secretase modulator (GSM) that blocks γ-secretase cleavage of amyloid-β protein precursor (AβPP) to generate the longer, 42-residue amyloid-β (Aβ42) without changing the production of total Aβ (e.g. CHF5074) [2].
|
|
References |
1. Green RC, Schneider LS, Amato DA, Beelen AP, Wilcock G, Swabb EA, Zavitz KH, Tarenflurbil Phase 3 Study Group. (2009)
Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial. JAMA, 302 (23): 2557-64. [PMID:20009055] |
2. Xia W, Wong ST, Hanlon E, Morin P. (2012)
γ-Secretase modulator in Alzheimer's disease: shifting the end. J Alzheimers Dis, 31 (4): 685-96. [PMID:22710916] |